Australian Clinical Labs Limited
ASX:ACL.AX
3.54 (AUD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 26.136 | 19.955 | 26.372 | 35.233 | 34.849 | 4.131 | 6.867 | 7.036 |
| Short Term Investments
| 0.709 | 0.632 | 1.134 | 1.049 | 0.435 | 1.001 | 2.914 | 0.301 |
| Cash and Short Term Investments
| 26.845 | 19.955 | 26.372 | 35.233 | 35.284 | 5.132 | 9.781 | 7.337 |
| Net Receivables
| 81.434 | 70.263 | 87.471 | 62.976 | 61.805 | 44.617 | 41.162 | 29.278 |
| Inventory
| 16.826 | 15.092 | 20.088 | 13.356 | 10.498 | 9.67 | 7.122 | 7.695 |
| Other Current Assets
| 8.496 | 10.017 | 7.806 | 4.612 | 4.513 | 5.386 | 12 | 14.037 |
| Total Current Assets
| 133.601 | 115.959 | 142.871 | 117.226 | 112.1 | 64.805 | 61.462 | 58.347 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 281.704 | 288.438 | 310.2 | 228.944 | 194.053 | 41.801 | 33.666 | 37.879 |
| Goodwill
| 158.684 | 158.684 | 158.684 | 105.983 | 35.748 | 35.748 | 13.002 | 13.002 |
| Intangible Assets
| 6.26 | 6.488 | 6.716 | 6.923 | 112.906 | 35.748 | 35.748 | 0 |
| Goodwill and Intangible Assets
| 164.944 | 165.172 | 165.4 | 112.906 | 35.748 | 35.748 | 13.002 | 13.002 |
| Long Term Investments
| 0 | 0 | 0 | -15.625 | 0.988 | 0.362 | 0.51 | 0 |
| Tax Assets
| 10.743 | 8.233 | 9.421 | 15.625 | 23.164 | 10.894 | 10.418 | 0 |
| Other Non-Current Assets
| 2.068 | 1.111 | 0.15 | 15.625 | 0 | 0 | 0 | 11.665 |
| Total Non-Current Assets
| 459.459 | 462.954 | 485.171 | 357.475 | 253.953 | 88.805 | 57.596 | 62.546 |
| Total Assets
| 593.06 | 578.913 | 628.042 | 474.701 | 366.053 | 153.61 | 119.058 | 120.893 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 26.187 | 17.966 | 26.468 | 17.025 | 12.89 | 11.975 | 9.121 | 7.466 |
| Short Term Debt
| 101.473 | 32.348 | -2.954 | 70.396 | 61.641 | 0 | 1.307 | 0.203 |
| Tax Payables
| 3.236 | 0.008 | 5.615 | 4.019 | 1.799 | 0 | 0.021 | 0 |
| Deferred Revenue
| 3.236 | 68.729 | 92.106 | 78.27 | 1.799 | 0 | 0.021 | 0 |
| Other Current Liabilities
| 70.335 | 0.137 | 6.207 | 74.736 | 55.538 | 54.42 | 46.994 | 46.572 |
| Total Current Liabilities
| 207.703 | 187.925 | 225.163 | 166.176 | 135.466 | 66.395 | 57.443 | 54.241 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 204.19 | 215.234 | 167.61 | 224.055 | 157.765 | 55.999 | 52.213 | 48.264 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 97.695 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0.018 | 0.008 | 0.003 | 0 |
| Other Non-Current Liabilities
| 3.402 | 3.083 | 2.712 | 2.556 | 3.834 | 3.788 | 3.944 | 4.266 |
| Total Non-Current Liabilities
| 207.592 | 218.317 | 170.322 | 226.611 | 161.599 | 59.795 | 56.157 | 52.53 |
| Total Liabilities
| 415.295 | 406.242 | 395.485 | 392.787 | 297.065 | 126.19 | 113.6 | 106.771 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 791.762 | 792.14 | 793.031 | 797.975 | 146.505 | 146.505 | 109.515 | 109.515 |
| Retained Earnings
| 159.054 | 155.241 | 216.22 | 62.194 | -120.288 | -120.288 | -233.836 | -224.824 |
| Accumulated Other Comprehensive Income/Loss
| -773.288 | -774.964 | -776.807 | -778.271 | 42.771 | 1.203 | 129.779 | 0.442 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 128.989 | 128.989 |
| Total Shareholders Equity
| 177.528 | 172.417 | 232.444 | 81.898 | 68.988 | 27.42 | 5.458 | 14.122 |
| Total Equity
| 177.765 | 172.671 | 232.557 | 81.914 | 68.988 | 27.42 | 5.458 | 14.122 |
| Total Liabilities & Shareholders Equity
| 593.06 | 578.913 | 628.042 | 474.701 | 366.053 | 153.61 | 119.058 | 120.893 |